SCHEMBL21710486

SCHEMBL21710486

CC(C)c1ccc(-c2ccc3c(c2)c2cc(-c4cccc5c4ccc4c5c5cccc6c7cc(-c8cccc(-c9ccccc9)c8)ccc7n4c65)cc4c5c6ccccc6ccc5n3c24)cc1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTSR1 P30989 2/20 0.32
AKR1C3 P42330 1/20 0.31
AKR1C2 P52895 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
AKR1B1 P15121 1/20 0.31
CHRNA1 P02708 1/20 0.30
CHRNG P07510 1/20 0.30
CHRNB1 P11230 1/20 0.30
CHRNB2 P17787 1/20 0.30
SLC6A2 P23975 1/20 0.30
CHRNB4 P30926 1/20 0.30
SLC6A4 P31645 1/20 0.30
CHRNA3 P32297 1/20 0.30
CHRNA4 P43681 1/20 0.30
SLC6A3 Q01959 1/20 0.30
CHRND Q07001 1/20 0.30
PIK3CD O00329 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21710697 0.96 NTSR1 (0.33) NTSR1AKR1C3AKR1C2CA12CA1
SCHEMBL22858087 0.89 PIK3CD (0.35) AKR1C3AKR1C2AKR1B1PIK3CD
SCHEMBL22868338 0.88 AKR1B1 (0.34) AKR1B1PIK3CD
SCHEMBL22679493 0.88 NTSR1 (0.31) NTSR1CHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL22679469 0.86 NTSR1 (0.34) NTSR1AKR1C3AKR1C2PIK3CD
SCHEMBL21717836 0.85 CHRNA1 (0.32) NTSR1CA12CA1CA2CA9
SCHEMBL22858086 0.83 PTGES (0.35) CA12CA1CA2CA9
SCHEMBL21710478 0.82 PTGES (0.34) AKR1B1PIK3CD
SCHEMBL21718136 0.82 PTGES (0.34) CA12CA1CA2CA9
SCHEMBL21718134 0.82 PTGES (0.35) CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11723272-B2 Organic electroluminescence element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-08 US disclosed
US-20200365812-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2020-11-19 US disclosed
US-20200052225-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-02-13 US disclosed
US-20200052212-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200052225-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE LEF1, L1CAM, ESR2 NTSR1 4819/4885AKR1C3 3504/4885AKR1C2 2929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.